These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20387098)

  • 21. Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.
    Winiwarter S; Ax F; Lennernäs H; Hallberg A; Pettersson C; Karlén A
    J Mol Graph Model; 2003 Jan; 21(4):273-87. PubMed ID: 12479927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple model for the prediction of corneal permeability.
    Fu XC; Liang WQ
    Int J Pharm; 2002 Jan; 232(1-2):193-7. PubMed ID: 11790503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopartitioning micellar chromatography as a predictive tool for skin and corneal permeability of newly synthesized 17β-carboxamide steroids.
    Dobričić V; Nikolic K; Vladimirov S; Čudina O
    Eur J Pharm Sci; 2014 Jun; 56():105-12. PubMed ID: 24607748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative structure-permeability relationships at various pH values for acidic and basic drugs and drug-like compounds.
    Oja M; Maran U
    SAR QSAR Environ Res; 2015; 26(7-9):701-19. PubMed ID: 26383235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicted permeability of the cornea to topical drugs.
    Edward A; Prausnitz MR
    Pharm Res; 2001 Nov; 18(11):1497-508. PubMed ID: 11758755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin permeation rate as a function of chemical structure.
    Katritzky AR; Dobchev DA; Fara DC; Hür E; Tämm K; Kurunczi L; Karelson M; Varnek A; Solov'ev VP
    J Med Chem; 2006 Jun; 49(11):3305-14. PubMed ID: 16722649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability.
    Dargó G; Vincze A; Müller J; Kiss HJ; Nagy ZZ; Balogh GT
    Eur J Pharm Sci; 2019 Feb; 128():232-239. PubMed ID: 30553815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR-based permeability model for drug-like compounds.
    Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
    Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictivity approach for quantitative structure-property models. Application for blood-brain barrier permeation of diverse drug-like compounds.
    Bolboacă SD; Jäntschi L
    Int J Mol Sci; 2011; 12(7):4348-64. PubMed ID: 21845082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach.
    Sharma C; Velpandian T; Biswas NR; Nayak N; Vajpayee RB; Ghose S
    J Biomed Biotechnol; 2011; 2011():483869. PubMed ID: 21403901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico prediction of membrane permeability from calculated molecular parameters.
    Refsgaard HH; Jensen BF; Brockhoff PB; Padkjaer SB; Guldbrandt M; Christensen MS
    J Med Chem; 2005 Feb; 48(3):805-11. PubMed ID: 15689164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal cell culture models: a tool to study corneal drug absorption.
    Dey S
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):529-32. PubMed ID: 21500964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans.
    Klopman G; Stefan LR; Saiakhov RD
    Eur J Pharm Sci; 2002 Dec; 17(4-5):253-63. PubMed ID: 12453615
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Tsanaktsidou E; Krestenitis M; Karavasili C; Zacharis CK; Fatouros DG; Markopoulou CK
    Drug Dev Ind Pharm; 2023 Mar; 49(3):249-259. PubMed ID: 37014319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.
    Grass GM; Robinson JR
    J Pharm Sci; 1988 Jan; 77(1):3-14. PubMed ID: 3126290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds.
    Yamazaki K; Kanaoka M
    J Pharm Sci; 2004 Jun; 93(6):1480-94. PubMed ID: 15124206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Simple Method to Predict Blood-Brain Barrier Permeability of Drug- Like Compounds Using Classification Trees.
    Castillo-Garit JA; Casanola-Martin GM; Le-Thi-Thu H; Pham-The H; Barigye SJ
    Med Chem; 2017; 13(7):664-669. PubMed ID: 28185535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
    Oja M; Maran U
    Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.